最新一期业绩显示，2025年半年报，公司实现营业收入2.17亿元，同比2.26%；净利润1051.51万元，同 比-51.69%，销售毛利率14.33%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13五洲医疗77.5869.333.6827.71亿行业平均 59.3254.705.08121.09亿行业中值39.9739.752.9659.06亿1九安医疗11.6111.740.91195.93亿2英科医疗 15.3516.551.37242.47亿3山东药玻16.3716.421.88154.82亿4新华医疗16.4015.201.34105.14亿5奥美医疗 17.1116.761.7661.81亿6九强生物17.8316.582.1888.30亿7振德医疗18.0617.021.1565.55亿8康德莱 18.2418.261.5139.31亿9奥泰生物18.5219.531.5059.06亿10维力医疗18.6319.902.3443.67亿11鱼跃医疗 20.4920.102.77362.90亿12安图生物20.9620.012.69238.97亿 来源：金融界 8月20日，五洲医疗今 ...

Core Viewpoint - Wuzhou Medical's stock closed at 38.6 yuan on July 28, with a 3.90% increase, and a rolling PE ratio of 73.48, marking a new low in 14 days, with a total market value of 2.625 billion yuan [1] Group 1: Company Performance - The company reported a revenue of 104 million yuan in Q1 2025, representing a year-on-year increase of 15.59% [1] - Net profit for the same period was 5.6345 million yuan, showing a year-on-year decrease of 43.00% [1] - The sales gross margin stood at 14.62% [1] Group 2: Industry Comparison - The average PE ratio for the medical device industry is 55.28, while the median is 38.06, placing Wuzhou Medical at the 96th position in the industry ranking [1][2] - The static PE ratio for Wuzhou Medical is 65.67, and the price-to-book ratio is 3.42 [2] - Other companies in the industry have varying PE ratios, with the lowest being 11.01 for Jiuan Medical and the highest being 20.05 for Sanxin Medical [2] Group 3: Capital Flow - On July 28, Wuzhou Medical experienced a net outflow of 1.549 million yuan in principal funds, although the overall trend over the past five days showed a net inflow of 12.1206 million yuan [1]

Company Overview - Wuzhou Medical's closing price on July 16 was 35.05 yuan, down 2.37%, with a rolling PE ratio of 66.73 times and a total market value of 2.383 billion yuan [1] - The company ranks 94th in the medical device industry, which has an average PE ratio of 51.87 times and a median of 37.48 times [1] Shareholder Information - As of June 30, 2025, Wuzhou Medical had 6,407 shareholders, an increase of 102 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Business Operations - Wuzhou Medical specializes in the research, development, manufacturing, and sales of disposable sterile infusion medical devices, as well as integrated supply of other diagnostic and nursing medical products [1] - Key products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, and various types of needles and medical masks [1] Financial Performance - In the first quarter of 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1]

Company Overview - Wuzhou Medical's closing price on July 10 was 37.26 yuan, down 5.43%, with a rolling PE ratio of 70.93 times and a total market value of 2.534 billion yuan [1] - The company ranks 95th in the medical device industry, which has an average PE ratio of 51.40 times and a median of 37.27 times [1] Shareholder Information - As of June 30, 2025, Wuzhou Medical had 6,407 shareholders, an increase of 102 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Business Operations - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, along with integrated supply of other diagnostic and nursing medical products [1] - Key products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, and various types of needles [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Wuzhou Medical, which closed at 28.82 yuan, marking a 2.38% increase, with a rolling PE ratio of 54.87, the lowest in 95 days, and a total market capitalization of 1.96 billion yuan [1] - Wuzhou Medical ranks 89th in the medical device industry based on PE ratio, with the industry average at 49.84 and the median at 36.59 [1][2] - As of the first quarter of 2025, three institutions hold shares in Wuzhou Medical, with a total of 293,800 shares valued at 0.08 million yuan [1] Group 2 - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, along with other diagnostic and nursing supplies [1] - The company's main products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, and various types of needles [1] - In the latest financial report for the first quarter of 2025, Wuzhou Medical reported revenue of 1.04 million yuan, a year-on-year increase of 15.59%, while net profit was 563,450 yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1]